BUSINESS OBJECTIVE
What needs to improve in your business?
Start with a challenge closest to yours. See what is at stake, what has to change and a comparable result from our prior work.
01
Transform Business & Change Management
02
Realize Value from AI
03
Improve Execution, Economics & Recovery
04
Accelerate Growth & Commercialization
05
Strengthen Investment and Governance
Advice is not the same as carrying the result
Leaders want decisions made, risks managed and the work moving with clear accountability. Carrying the result means the principal steps in directly to challenge entrenched assumptions, resolve resistance and execute the operating rhythm the mandate needs.
01
Validate buyer demand, business-case economics and go-to-market channels against capacity.
02
Balance margin, capacity, controls, time and operational tradeoffs under budget pressure.
Bring commercial and operating commitments into line with the resources, constraints and controls required to deliver.
03
Resolve resistance, drive adoption and establish urgency and cadence.
Aligning roles, workflows, decision rights and operating cadence so strategic mandates translate into daily execution.
04
Use evidence to advance, pivot, pause or stop before capital is wasted.
Establishing explicit Go / No-Go gates and measurable quality thresholds before committing further capital.
Principal Results as CEO, Founder, Senior Operator
THE DIFFERENCE OPERATING EXPERIENCE MAKES
What the principal changed and what the evidence shows
Explore prior work in commercialization, program recovery, AI and governance. Each case shows the business challenge, what changed and the result.
From AI Strategy to Governed RFP Intelligence
CHALLENGE
A buy-side asset manager needed faster institutional RFP responses without replacing its existing platform or weakening regulated disclosure review.
WHAT CHANGED
Governed AI drafting was added to the existing workflow with traceable sources, acceptance checks and mandatory human sign-off.
MEASURED / MODELED EVIDENCE
97%
First-pass accuracy in iterative QA
55 sec
Average first-pass generation time
SCOPE / CONTROL
Existing RFP platform retained; human release controls.
Orthopedic Platform Under Bundled Payment Risk
CHALLENGE
An orthopedic device platform needed credible buyer economics under bundled-payment risk before the board committed further commercialization capital.
WHAT CHANGED
Clinical beta findings were connected to episode-of-care economics across 1,407 surgical episodes to assess buyer value before scaling.
MEASURED / MODELED EVIDENCE
$1.86M
Modeled net impact—not realized savings
1,407
Surgical episodes in buyer model
SCOPE / CONTROL
Prospective buyer economics; modeled outcomes are not realized savings.
Faster e-Discovery Under Protective Order
CHALLENGE
Counsel faced fixed deposition deadlines and roughly 100,000 mixed records subject to a protective order and defensible review requirements.
WHAT CHANGED
A controlled AI-assisted classification workflow separated factual material from pleadings while retaining source traceability, privilege boundaries and counsel oversight.
MEASURED / MODELED EVIDENCE
42d → 2.5d
First-pass review cycle
~100K
Mixed-format litigation records classified
SCOPE / CONTROL
Protective-order conditions and counsel decision control retained.
THE VALUE CONVERSATION
Start with the business result worth funding
- Objective:What should improve, for whom and by when?
- Measure:What is happening today, and what change would prove progress?
- Value:What financial or strategic gain would make the work worth funding?
MEASURES OF SUCCESS
Qualified buyers, proposals, signed contracts, revenue and time to close each sale.
VALUE OF IMPROVEMENT
More revenue and profit after the costs of winning and serving those customers.
BUSINESS OBJECTIVE
Improve profit and delivery performance in an existing business.
MEASURES OF SUCCESS
Operating margin, missed service targets, contract penalties and time to deliver.
VALUE OF IMPROVEMENT
Higher operating profit, fewer penalties and more time available for productive work.
RELEVANT OPERATING EVIDENCE
Clinical registry modernization · $1M+ build path avoided
BUSINESS OBJECTIVE
Reduce routine screening work so specialists can focus on cases that need judgment.
MEASURES OF SUCCESS
Time per review, false alerts, source evidence and specialist approval quality.
VALUE OF IMPROVEMENT
Fewer hours spent on false alarms and more specialist capacity for important decisions.
BUSINESS OBJECTIVE
Find a market with buyers before committing more product and expansion capital.
MEASURES OF SUCCESS
Buyer demand, willingness to pay, purchase access and time to an advance or stop decision.
VALUE OF IMPROVEMENT
Avoid spending on weak markets and direct capital toward opportunities with real demand.
What business result do you need?
Advisory Services & Capabilities
Match our expertise to your mandate
HOW WE WORK
Match the engagement to the mandate
01 · ADVICE & SCOPED PROJECTS
Focused Advisory
Best when: a defined decision or scoped project needs evidence, options and next steps.
02 · CROSS-FUNCTIONAL DIRECTION
Program Leadership
Best when: cross-functional execution needs ongoing senior direction across teams and functions.
03 · SUSTAINED LEADERSHIP
Fractional & Interim Leadership
Best when: sustained operating or commercial leadership is needed without adding permanent headcount.
How our engagements work
Start with the business objective and the work required. Agree on scope, accountabilities, timelines, success measures and relevant decision gates before selecting the level of senior involvement.
Clarify the Mandate
Define the decision or project, business objectives, accountable sponsor, risks, assumptions and future state.
Establish Measures & Decision Gates
Agree on success measures, timelines, milestones and the conditions needed to proceed or change direction.
Select Engagement Model
Choose focused advisory, program leadership or fractional and interim operating leadership.
Advance the Agreed Work
Deliver scoped advisory work or lead the agreed operating mandate. Set a review cadence and check progress against the agreed measures & evidence.


